A Study Assessing Contrast-Enhanced Mammography for Women with Palpable Breast Abnormalities

Full Title

Use of Contrast Enhanced Spectral Mammography (CESM) for Women with Palpable Breast Abnormalities

Purpose

The use of a special dye (contrast agent) may improve the ability of mammography to detect breast cancer. The purpose of this study is to evaluate contrast-enhanced spectral mammography in women who have breast lumps.

Prior to starting the regular mammogram, a marker will be placed on the breast where the woman feels a lump. The woman will then receive the contrast dye through a vein. After the dye is given, she will undergo the four routine mammography views, along with a special view over the lump. This is the standard approach for any woman who has a lump. Because this is done with a special mammography machine, two kinds of images are actually generated for each exposure. Doctors want to see if adding the dye enhances their ability to identify the cause of the lump compared with regular mammography alone.

Then, as is standard practice, the woman will have an ultrasound to evaluate the lump.

Eligibility

This study is for women age 25 and older who have breast lumps that can be felt and need to be evaluated by mammography.

For more information about this study and to inquire about eligibility, please contact Girard Gibbons at 646-888-4857 or Elizabeth Manderski at 646-888-4516.

Protocol

15-053

Investigator

Co-Investigators

Diseases

Locations